| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 1wx | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319 | 5liw | 98.64 |
| 2 | mk4 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK184 | 5lix | 94.07 |
| 3 | zst | Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestat | 4jii | 91.02 |
| 4 | tol | Crystal Structure Of AKR1B10 Complexed With NADP+ And Tolrestat | 1zua | 90.89 |
| 5 | flf | Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acid | 4i5x | 88.03 |
| 6 | 388 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor IDD388 | 5liu | 87.57 |
| 7 | w8x | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK181 | 5lik | 87.53 |
| 8 | fid | Human AKR1B10 mutant V301L complexed with NADP+ and fidarestat | 4gab | 87.42 |
| 9 | qap | Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl ester | 4gq0 | 84.87 |
| 10 | suz | Crystal structure of human AKR1B10 complexed with NADP+ and sulindac | 4wev | 84.24 |
| 11 | uv8 | Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008 | 5m2f | 83.68 |
| 12 | 8ql | Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diol | 5y7n | 83.03 |